Genotoxic Impurities
Faced with new guidelines that many find constraining, pharmaceutical manufacturers are seeking ways to avoid or reduce harmful contaminants in drugs
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
September 27, 2010 Cover
Volume 88, Issue 39
Faced with new guidelines that many find constraining, pharmaceutical manufacturers are seeking ways to avoid or reduce harmful contaminants in drugs
Credit:
Faced with new guidelines that many find constraining, pharmaceutical manufacturers are seeking ways to avoid or reduce harmful contaminants in drugs
ACS Meeting News: Technology provides more options, but print textbooks will remain, at least for now
Private equity firms are investing in the risky business of fine and pharmaceutical chemical manufacturing
ACS Meeting News: Small molecules that interact with DNA are bound to regulate gene expression
ACS Meeting News: JAK2 inhibitors show promise at knocking down the symptoms of rare blood cancers
New leadership will examine environmental methods, test alternative recruitment strategies
ACS Meeting News: Interactions between medications, foods, and supplements take many forms